“We're able to deliver different types of gene therapies in a closed system," Lupagen's CEO says, calling the tech a "bridge to the future."
MORE►
Cormorant Asset Management
Video still from Lupagen's website. [Image: Lupagen}
Dallas’ Lupagen Aims To Change the Way Cancer, Other Disorders Are Treated
by Kevin Cummings | Jun 2, 2022
Instead of shipping a patient's blood to a lab for customized cell therapy, Lupagen does the procedure "in vivo," using a dialysis-like treatment at the patient's bedside. Now it's collaborating with Umoja Biopharma to use its drug-delivery tech to place targeted immunotherapies in patients.
“We're able to deliver different types of gene therapies in a closed system," Lupagen's CEO says, calling the tech a "bridge to the future."
“We're able to deliver different types of gene therapies in a closed system," Lupagen's CEO says, calling the tech a "bridge to the future."
![Plano-based inventor Swaminathan Balasubramanian has received a newly granted patent for an "Energy Efficient Legged Mobile Robot." The patent describes a robot with a non-inverted pendulum body and articulated leg system designed to move like a humanoid, carry heavy loads, and minimize joint strain using a self-compensating mass structure. [Source images: USPTO Patent #12263899, left to right: Fig. 1, Fig. 2, Fig. 4; DI Studio background]](https://s24806.pcdn.co/wp-content/uploads/2025/05/Patent-12263899-Utility-robot-patent-fig1-2-4.jpg)
